Catalyst Wire Dossier Catalyst Wire Dossier

Human Umbilical Cord Mesenchymal Stem Cells

· Shanghai East Hospital
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for Human Umbilical Cord Mesenchymal Stem Cells, covering 2011-10-14 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease [Phase 1, Phase 2]

See pricing